Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2314
Gene Symbol: FLII
FLII
0.010 Biomarker disease BEFREE Drinking habits among adults during midlife affect the development of fatty liver, and sustained heavy drinking is associated with an increased FLI compared to stable low-risk drinkers. 30463051 2019
Entrez Id: 6611
Gene Symbol: SMS
SMS
0.010 Biomarker disease BEFREE Gender race/ethnicity, marital status, mode of transport used to purchase alcohol, perceptions of alcohol availability and exposure to alcohol promotions and advertising through SMS and free offers when buying alcohol all impacted heavy drinking. 31076000 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 Biomarker disease BEFREE Among HIV+ adults, current heavy alcohol use is associated with higher sCD14, IL-6 and D-dimer over time. 31437155 2019
Entrez Id: 9048
Gene Symbol: ARTN
ARTN
0.010 Biomarker disease BEFREE We found no interactions with heavy alcohol use on retention in care or maintaining ART prescription or with other substances for any outcome. 30269230 2019
Entrez Id: 805
Gene Symbol: CALM2
CALM2
0.010 Biomarker disease BEFREE CAMI was hypothesized to reduce heavy drinking days and frequency of alcohol-related consequences more than MI. 31403817 2019
Entrez Id: 801
Gene Symbol: CALM1
CALM1
0.010 Biomarker disease BEFREE CAMI was hypothesized to reduce heavy drinking days and frequency of alcohol-related consequences more than MI. 31403817 2019
Entrez Id: 181
Gene Symbol: AGRP
AGRP
0.010 Biomarker disease BEFREE We found no interactions with heavy alcohol use on retention in care or maintaining ART prescription or with other substances for any outcome. 30269230 2019
Entrez Id: 808
Gene Symbol: CALM3
CALM3
0.010 Biomarker disease BEFREE CAMI was hypothesized to reduce heavy drinking days and frequency of alcohol-related consequences more than MI. 31403817 2019
Entrez Id: 5966
Gene Symbol: REL
REL
0.010 GeneticVariation disease BEFREE Non-treatment-seeking underage drinkers who reported past-month heavy drinking (N = 167; ages 17 to 20; 42% female; 59% non-Hispanic White) were randomly assigned to receive a single session of BMI or REL. 29750362 2018
Entrez Id: 29997
Gene Symbol: NOP53
NOP53
0.010 Biomarker disease BEFREE We observed an increase in the global mean field power in the time window of 54- to 75-millisecond post-TMS, as well as significant topographical differences in the P60 and N100 in those with a history of heavy drinking. 28008690 2018
Entrez Id: 7132
Gene Symbol: TNFRSF1A
TNFRSF1A
0.010 Biomarker disease BEFREE We observed an increase in the global mean field power in the time window of 54- to 75-millisecond post-TMS, as well as significant topographical differences in the P60 and N100 in those with a history of heavy drinking. 28008690 2018
Entrez Id: 3437
Gene Symbol: IFIT3
IFIT3
0.010 Biomarker disease BEFREE We observed an increase in the global mean field power in the time window of 54- to 75-millisecond post-TMS, as well as significant topographical differences in the P60 and N100 in those with a history of heavy drinking. 28008690 2018
Entrez Id: 115482683
Gene Symbol: H3P7
H3P7
0.010 Biomarker disease BEFREE We observed an increase in the global mean field power in the time window of 54- to 75-millisecond post-TMS, as well as significant topographical differences in the P60 and N100 in those with a history of heavy drinking. 28008690 2018
Entrez Id: 8878
Gene Symbol: SQSTM1
SQSTM1
0.010 Biomarker disease BEFREE We observed an increase in the global mean field power in the time window of 54- to 75-millisecond post-TMS, as well as significant topographical differences in the P60 and N100 in those with a history of heavy drinking. 28008690 2018
Entrez Id: 7984
Gene Symbol: ARHGEF5
ARHGEF5
0.010 Biomarker disease BEFREE We observed an increase in the global mean field power in the time window of 54- to 75-millisecond post-TMS, as well as significant topographical differences in the P60 and N100 in those with a history of heavy drinking. 28008690 2018
Entrez Id: 10963
Gene Symbol: STIP1
STIP1
0.010 Biomarker disease BEFREE We observed an increase in the global mean field power in the time window of 54- to 75-millisecond post-TMS, as well as significant topographical differences in the P60 and N100 in those with a history of heavy drinking. 28008690 2018
Entrez Id: 55821
Gene Symbol: ALLC
ALLC
0.010 Biomarker disease BEFREE This randomized clinical trial will evaluate the feasibility and initial efficacy of TSP + ALC compared to TSP with 225 US young adult smokers reporting heavy drinking. 29510223 2018
Entrez Id: 2875
Gene Symbol: GPT
GPT
0.010 Biomarker disease BEFREE The following known risk factors for liver disease/cancer were evaluated: elevated aminotransferase levels (elevated alanine aminotransferase was defined as > 40 IU/L for males and females; elevated aspartate aminotransferase was defined as > 40 IU/L for males and females), infection with hepatitis B or hepatitis C, metabolic syndrome, high total cholesterol, diabetes, obesity, abdominal obesity, and heavy alcohol use. 30310261 2018
Entrez Id: 263
Gene Symbol: AMD1P2
AMD1P2
0.010 Biomarker disease BEFREE We noted an effect on the percentage of days abstinent in the past 14 days (adjusted mean difference [AMD] 16·0% [8·1-24·1]; p<0·0001), but no effect on the percentage of days of heavy drinking (AMD -0·4% [-5·7 to 4·9]; p=0·88), the effect of drinking (Short Inventory of Problems score AMD-0·03 [-1·93 to 1·86]; p=0.97), disability score (WHO Disability Assessment Schedule score AMD 0·62 [-0·62 to 1·87]; p=0·32), days unable to work (no days unable to work adjusted odds ratio 1·02 [0·61-1·69]; p=0.95), suicide attempts (adjusted prevalence ratio 1·8 [-2·4 to 6·0]; p=0·25), and intimate partner violence (adjusted prevalence ratio 3·0 [-10·4 to 4·4]; p=0·57). 27988144 2017
Entrez Id: 1958
Gene Symbol: EGR1
EGR1
0.010 Biomarker disease BEFREE Here, we describe research on the involvement of the transcription factor, Early Growth Response- 1 (Egr-1) in alcohol-induced liver injury, specifically, fatty liver (steatosis), one of the earliest and most frequent signs of liver injury that occurs after heavy drinking. 26278386 2017
Entrez Id: 857
Gene Symbol: CAV1
CAV1
0.010 GeneticVariation disease BEFREE A synergistic effect between eNOS and Cav-1 polymorphisms on IS risk elevation was significantly influenced by alcohol drinking, heavy cigarette smoking (P-trend<0.01), and hypercholesterolemia (P-trend < 0.001). 28346478 2017
Entrez Id: 255239
Gene Symbol: ANKK1
ANKK1
0.010 GeneticVariation disease BEFREE The association of the DRD2/ANKK1 TaqIA polymorphism with heavy drinking was estimated. 28152448 2017
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.010 Biomarker disease BEFREE We noted an effect on the percentage of days abstinent in the past 14 days (adjusted mean difference [AMD] 16·0% [8·1-24·1]; p<0·0001), but no effect on the percentage of days of heavy drinking (AMD -0·4% [-5·7 to 4·9]; p=0·88), the effect of drinking (Short Inventory of Problems score AMD-0·03 [-1·93 to 1·86]; p=0.97), disability score (WHO Disability Assessment Schedule score AMD 0·62 [-0·62 to 1·87]; p=0·32), days unable to work (no days unable to work adjusted odds ratio 1·02 [0·61-1·69]; p=0.95), suicide attempts (adjusted prevalence ratio 1·8 [-2·4 to 6·0]; p=0·25), and intimate partner violence (adjusted prevalence ratio 3·0 [-10·4 to 4·4]; p=0·57). 27988144 2017
Entrez Id: 2626
Gene Symbol: GATA4
GATA4
0.010 GeneticVariation disease BEFREE We have previously demonstrated that the GATA4 single nucleotide polymorphism (SNP) rs13273672 revealed stronger alcohol-specific amygdala activation associated with lowered relapse risk to heavy drinking at 90 days in the AA-homozygotes. 27397865 2016
Entrez Id: 2289
Gene Symbol: FKBP5
FKBP5
0.010 GeneticVariation disease BEFREE The absence of an interaction between either current life stress or past-year trauma, and FKBP5 genotype on heavy drinking suggests that there exists a developmental period of susceptibility to stress that is moderated by FKBP5 genotype. 27196697 2016